Evoke Pharma Cash Flow - Annual (NASDAQ:EVOK)

Add to My Stocks
$2.73 $0.04 (1.44%) EVOK stock closing price Jun 19, 2018 (Closing)

The Evoke Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows Evoke Pharma profits, the balance sheet shows Evoke Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Evoke Pharma saw a cash impact of $7.38M from the issuance of EVOK shares. The cash flow statement helps in the Evoke Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Evoke Pharma has a negative cash and cash equivalents change of $-1.32M.

View details of Evoke Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Net Income Cash Flow
-12.22M-10.74M-12.12M-13.24M-2.83M-2.01M-2.4M
Depreciation Depletion Amortization Cash-Flow-------
Net Increase (Decrease) in Assets Liabilities-----0.46M--0.51M
Cash From (used in) Discontinued Operations-------
Other Adjustments Net2.82M1.76M1.54M1.16M---
Net Cash from (used by) Operating Activities
-8.71M-8.7M-10.49M-11.5M-3.04M-1.74M-2.89M
Increase (Decrease) in Prop Plant And Equipment-------
Acquisition Disposition of Subsidiaires-------
Increase (Decrease) in Investments-------
Other Cash Inflow (Outflow) from Investment Activities-------
Net Cash from (used by) Investment Activities
-------
Issuance (Purchase) of Equity Shares7.38M13.52M5.03M-25.12M--
Issuance (Repayment) of Debt Securities--4.5M-1.5M2M1M-0.27M
Increase (Decrease) in Bank & Other Borrowings-------
Payment of Dividends & Other Cash Distributions-------
Other Cash from (used by) Financing Activities----0.08M---
Net Cash from (used by) Financing Activities
7.38M9.02M5.03M1.46M27.12M1M-0.27M
Effect of Exchange Rate Changes on Cash-------
Net Change in Cash & Cash Equivalents
-1.32M--5.46M-10.04M24.08M-0.74M-3.17M
Cash & Equivalents at Beginning of Year9M8.69M14.15M24.19M--4.03M
Cash & Equivalents at Year End7.67M9M8.69M14.15M24.19M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Evoke Pharma stock price history and Evoke Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Evoke Pharma had a Net Change in Cash and Cash Equivalents of $-1.32M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Evoke Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-8.71M for EVOK.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for EVOK in last 2017 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $7.38M for Evoke Pharma.

Key Financial Ratios For Evoke Pharma Cash Flow